Results 161 to 170 of about 117,810 (327)

HASHIMOTO’S THYROIDITIS WITH SYSTEMIC INVOLVEMENT

, 2023
Jianmin Tang, Quinncy Lee, Nur Syafiqah Hamizi, Nurshadia Samingan, Azriyanti Anuar Zaini, Muhammad Yazid Jalaludin   +5 more
openalex   +2 more sources

Joint Society Statement From the Society for Endocrinology (SfE), the British Thyroid Association (BTA) and the British Association of Endocrine and Thyroid Surgeons (BAETS) Regarding the Association of GLP‐1 Agonists and Thyroid Cancer

Clinical Endocrinology, EarlyView.
Emma Watts, Jonathan Wadsley, Neil Sharma, Kristien Boelaert, The UK Thyroid Cancer Study Group   +4 more
wiley   +1 more source

Enfortumab vedotin plus pembrolizumab in treatment‐naïve metastatic urothelial carcinoma patients: An Austrian real‐world analysis

International Journal of Cancer, Volume 158, Issue 6, Page 1654-1665, 15 March 2026.
What's new? New antibody‐drug conjugates (ADCs) and immunotherapies have helped expand treatment options for urothelial carcinoma (UC). Clinical trials suggest that the ADC enfortumab vedotin (EV) and the immunotherapeutic agent pembrolizumab, when used in combination, are especially effective against UC.
Dora Niedersuess‐Beke, Karl Mayrhofer, Johanna Krauter, Johannes Franke, Dominic Vais, Maximillian Pallauf, David Kiesl, Ferdinand Luger, Jacob Pfuner, Angelika Terbuch, Thomas Bauernhofer, Jasmin Spielgelberg, Andreas Banner, Stefan Aufderklamm, Clemens Wiesinger, Susanne Schnabel, Simon Peter Gampenrieder, Josef Mühlmann, Sonia Vallet, Sabine Weibrecht, Franz Stoiber, Haleh Andalibi, Harun Fajkovic, Hossein Taghizadeh, Jan Miechowiecki, Roman Taedcke, Daniel Heintel, Shahrokh F. Shariat, Martin Pichler, Wolfgang Hilbe, Renate Pichler   +30 more
wiley   +1 more source

Induction of granulomatous experimental autoimmune thyroiditis in mice with in vitro activated effector T cells and anti-IFN-gamma antibody. [PDF]

, 1992
Susan J. Stull, Gordon C. Sharp, Michael Kyriakos, John T. Bickel, Helen Braley‐Mullen   +4 more
openalex   +1 more source

SARS-CoV-2-related atypical thyroiditis

The Lancet Diabetes and Endocrinology, 2020
I. Muller, Daniele Cannavaro, D. Dazzi, D. Covelli, G. Mantovani, A. Muscatello, E. Ferrante, E. Orsi, V. Resi, V. Longari, Marco Cuzzocrea, A. Bandera, Elisa Lazzaroni, A. Dolci, F. Ceriotti, T. Re, A. Gori, M. Arosio, M. Salvi   +18 more
semanticscholar   +1 more source

Sex Matters: Hormonal and Chromosomal Determinants of Autoimmunity and Anti‐Cancer Immunity Across the Lifespan

Immunological Reviews, Volume 338, Issue 1, March 2026.
ABSTRACT Sex plays a key role in shaping both anti‐cancer immunity and autoimmunity. Biological factors underlying sexual dimorphism have now been identified in multiple aspects of anti‐cancer immunity and autoimmunity. These factors include sex differences in hormone levels, chromosome complement, and expression of the long non‐coding RNA XIST.
Christian G. Bustillos, Esther M. Peluso, Sophia L. Cha, Melissa G. Lechner, Maureen A. Su   +4 more
wiley   +1 more source

Intrathyroidal thyroglossal duct cyst presenting as chronic thyroiditis: Case report and narrative review of the literature

, 2020
Husam Aldean H. Hussain, Javaid Hassaan, Rallabandi Hima Bindu, Wani Fozia Jeelani   +3 more
openalex   +1 more source

The X Factor in Immunity: Sex Differences Shaped by the X Chromosome

Immunological Reviews, Volume 338, Issue 1, March 2026.
ABSTRACT There are sex differences with immune responses where females exhibit stronger immune responses compared to males. Both sex hormones and sex chromosome differences between males and females contribute to the observed sex differences with innate and adaptive immune cell composition and function.
Katherine B. Radovanovic, Megan Wynalda, Montserrat C. Anguera   +2 more
wiley   +1 more source

Antibodies to Plasmid-encoded Proteins of enteropathogenic Yersinia in Patiens with autoimmune Thyroid Disease [PDF]

, 1988
Bech, Bech, BjörnE. Wenzel, Heesemann, Heesemann, Heesemann, Heesemann, Jürgen Heesemann, KlausW. Wenzel, Lidman, PeterC. Scriba, Weiss, Wenzel, Zink   +13 more
core   +6 more sources

Exceptional therapeutic benefit of imatinib in cKIT‐mutated mucosal melanoma followed by a KIT mutation loss

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Hannah Zillikens, Corinna Scheib, Vicky Peller, Christina Müller, Sebastian Bauer, Ina Pretzell, Klaus Griewank, Antje Sucker, Eva Hadaschik, Felicitas Guntrum, Sven Holger Baum, Alexander Roesch, Selma Ugurel, Dirk Schadendorf, Lisa Zimmer, Elisabeth Livingstone   +15 more
wiley   +1 more source